Companion Animal Pharmaceuticals Market by Indication (Infectious Diseases, Antibiotics, Parasiticides, Vaccines, Pain), Animal Type (Dogs, Cats, Horses), Distribution Channel (Veterinary Hospitals & Clinics), COVID-19 Impact - Global Forecast to 2026

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2              MARKETS COVERED.. 27
・       FIGURE 1.......... COMPANION ANIMAL PHARMACEUTICALS MARKET SEGMENTATION
1.2.3              YEARS CONSIDERED FOR THE STUDY
1.3             CURRENCY
・       TABLE 1... EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.4             STAKEHOLDERS
1.5             LIMITATIONS

2.... RESEARCH METHODOLOGY

2.1             RESEARCH APPROACH
・       FIGURE 2.................................................. RESEARCH DESIGN.. 29
2.1.1              SECONDARY RESEARCH
2.1.1.1            KEY DATA FROM SECONDARY SOURCES
2.1.2              PRIMARY RESEARCH.. 31
2.1.2.1            PRIMARY SOURCES
2.1.2.2            KEY DATA FROM PRIMARY SOURCES
2.1.2.3            KEY INDUSTRY INSIGHTS
2.1.2.4            BREAKDOWN OF PRIMARIES
・       FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2             MARKET SIZE ESTIMATION
・       FIGURE 4..... MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
・       FIGURE 5........... REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS
・       FIGURE 6....... SUPPLY-SIDE ANALYSIS OF THE COMPANION ANIMAL PHARMACEUTICALS MARKET
・       FIGURE 7.................................... MARKET ANALYSIS APPROACH
・       FIGURE 8..... US: COMPANION ANIMAL PHARMACEUTICALS MARKET APPROACH
・       FIGURE 9.............................................. TOP-DOWN APPROACH.. 39
・       FIGURE 10............................................... CAGR PROJECTIONS.. 40
・       FIGURE 11............... DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE COMPANION ANIMAL PHARMACEUTICALS MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR
2.3             DATA TRIANGULATION APPROACH
・       FIGURE 12......................... DATA TRIANGULATION METHODOLOGY
2.4             MARKET SHARE ESTIMATION
2.5             ASSUMPTIONS FOR THE STUDY
2.6             RISK ASSESSMENT/LIMITATIONS
2.7             COVID-19 HEALTH ASSESSMENT
2.8             COVID-19 ECONOMIC ASSESSMENT
2.9             ASSESSING THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
・       FIGURE 13................ CRITERIA IMPACTING THE GLOBAL ECONOMY
・       FIGURE 14........... RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3.... EXECUTIVE SUMMARY

・       FIGURE 15.... COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2021 VS. 2026 (USD MILLION)
・       FIGURE 16.... COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2021 VS. 2026 (USD MILLION)
・       FIGURE 17.... COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2021 VS. 2026 (USD MILLION)
・       FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE COMPANION ANIMAL  PHARMACEUTICALS MARKET. 50

4.... PREMIUM INSIGHTS

4.1             COMPANION ANIMAL PHARMACEUTICALS MARKET OVERVIEW
・       FIGURE 19...... RISING PET POPULATION TO DRIVE MARKET GROWTH
4.2             EUROPE: COMPANION ANIMAL PHARMACEUTICALS MARKET,  BY INDICATION AND COUNTRY (2020)
・       FIGURE 20.. INFECTIOUS DISEASES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN MARKET IN 2020
4.3             COMPANION ANIMAL PHARMACEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES.. 54
・       FIGURE 21.. CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
4.4             COMPANION ANIMAL PHARMACEUTICALS MARKET, BY REGION (2019–2026)
・       FIGURE 22....... NORTH AMERICA WILL CONTINUE TO DOMINATE THE COMPANION ANIMAL PHARMACEUTICALS MARKET DURING THE FORECAST PERIOD
4.5             COMPANION ANIMAL PHARMACEUTICALS MARKET:  DEVELOPED VS. DEVELOPING MARKETS
・       FIGURE 23. DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       TABLE 2. COMPANION ANIMAL PHARMACEUTICALS MARKET: IMPACT ANALYSIS
5.2.1              MARKET DRIVERS
5.2.1.1            GROWING PREVALENCE OF ZOONOTIC DISEASES
・       TABLE 3.. ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2013–2018)
5.2.1.2            RISING DEMAND FOR PET INSURANCE WITH GROWING ANIMAL HEALTH EXPENDITURE
・       FIGURE 24.......... US: PET EXPENDITURE, 2010-2019 (USD BILLION)
・       FIGURE 25..... US: PET HEALTH INSURANCE MARKET, 2014 VS. 2019 (USD MILLION)
5.2.1.3            GROWING INVESTMENTS BY KEY PLAYERS
5.2.1.4            INITIATIVES BY VARIOUS GOVERNMENT AGENCIES AND ANIMAL ASSOCIATIONS.. 60
5.2.1.5            GROWTH IN COMPANION ANIMAL OWNERSHIP RATES
・       FIGURE 26........... DEVELOPED COUNTRIES: PET POPULATION & PET OWNERSHIP
5.2.2              MARKET RESTRAINTS.. 63
5.2.2.1            RISING PET CARE COSTS
5.2.2.2            LIMITED NUMBER OF NEW PRODUCT DEVELOPMENTS
5.2.2.3            HIGH STORAGE COST OF VACCINES
5.2.3              MARKET OPPORTUNITIES
5.2.3.1            LUCRATIVE GROWTH OPPORTUNITIES IN EMERGING MARKETS
5.2.3.2            GROWING PREVALENCE OF ANIMAL DISEASES
5.2.3.3            TECHNOLOGICAL ADVANCEMENTS IN MANUFACTURING VACCINES
5.2.4              MARKET CHALLENGES.. 66
5.2.4.1            STRINGENT REGULATORY APPROVAL PROCESS FOR DRUGS
5.2.4.2            INADEQUATE SURVEILLANCE AND REPORTING SYSTEMS OF VACCINES
5.2.4.3            DIVERSITY OF PARASITE SPECIES

6.... INDUSTRY INSIGHTS

6.1             INTRODUCTION
6.2             INDUSTRY TRENDS
6.2.1              GROWING CONSOLIDATION IN THE ANIMAL HEALTHCARE INDUSTRY
・       TABLE 4..... MAJOR ACQUISITIONS IN THE ANIMAL HEALTH INDUSTRY (2017–2019)
6.2.2              INNOVATIONS IN ANIMAL HEALTHCARE PRODUCTS
・       TABLE 5............... INNOVATIVE ANIMAL PHARMACEUTICAL TRENDS
6.3             PORTER’S FIVE FORCES ANALYSIS
・       TABLE 6.................................. PORTER’S FIVE FORCES ANALYSIS
6.3.1              THREAT OF NEW ENTRANTS
6.3.2              THREAT OF SUBSTITUTES
6.3.3              BARGAINING POWER OF SUPPLIERS
6.3.4              BARGAINING POWER OF BUYERS
6.3.5              INTENSITY OF COMPETITIVE RIVALRY
6.4             REGULATORY ANALYSIS
・       FIGURE 27.............. DEVELOPMENT AND APPROVAL PROCESS FOR COMPANION ANIMAL PHARMACEUTICAL PRODUCTS
・       TABLE 7............ US: RECENT DEVELOPMENTS IN REGULATIONS FOR VETERINARY DRUGS
・       FIGURE 28......... EUROPE: COMPANION ANIMAL PHARMACEUTICAL PRODUCTS APPROVAL PROCESS
6.5             VALUE CHAIN ANALYSIS
・       FIGURE 29....... COMPANION ANIMAL PHARMACEUTICALS MARKET: VALUE CHAIN ANALYSIS
6.6             SUPPLY CHAIN ANALYSIS
・       FIGURE 30....... COMPANION ANIMAL PHARMACEUTICALS MARKET: SUPPLY CHAIN ANALYSIS
6.7             ECOSYSTEM ANALYSIS
6.7.1              ECOSYSTEM ANALYSIS FOR THE COMPANION ANIMAL PHARMACEUTICALS MARKET
・       FIGURE 31....... COMPANION ANIMAL PHARMACEUTICALS MARKET: ECOSYSTEM ANALYSIS
6.8             IMPACT OF COVID-19 ON THE COMPANION ANIMAL PHARMACEUTICALS MARKET
6.9             PATENT ANALYSIS
6.9.1              TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR COMPANION ANIMAL PHARMACEUTICALS
・       FIGURE 32........ TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR COMPANION ANIMAL PHARMACEUTICAL PATENTS (2015–2020) 81
6.9.2              TOP INVENTORS FOR COMPANION ANIMAL PHARMACEUTICALS
・       FIGURE 33................... TOP INVENTORS FOR COMPANION ANIMAL PHARMACEUTICALS PATENTS (2015–2020)
6.9.3              JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR COMPANION ANIMAL PHARMACEUTICALS
・       FIGURE 34.... TOP APPLICANT COUNTRIES FOR COMPANION ANIMAL PHARMACEUTICAL PATENTS (2015–2020)

7.... COMPANION ANIMAL PHARMACEUTICALS MARKET,  BY INDICATION

7.1             INTRODUCTION
・       TABLE 8....... COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
7.2             INFECTIOUS DISEASES
・       TABLE 9...... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 10.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES,  BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1              PARASITICIDES
7.2.1.1            GROWING REGULATORY GUIDELINES TO PREVENT THE SPREAD OF PARASITE-CAUSED DISEASES IS FUELING THE MARKET GROWTH
・       TABLE 11.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR PARASITICIDES, BY COUNTRY, 2019–2026 (USD MILLION). 88
7.2.2              VACCINES
7.2.2.1            RISING AWARENESS AMONG PET OWNERS FOR VACCINATING DOGS AND CATS TO DRIVE MARKET GROWTH
・       TABLE 12.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR VACCINES, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3              ANTIBIOTICS AND ANTIMICROBIALS
7.2.3.1            ANTIBIOTICS AND ANTIMICROBIALS HELP COMBAT CLINICAL AND SUBCLINICAL DISEASES IN ANIMALS
・       TABLE 13.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR ANTIBIOTICS AND ANTIMICROBIALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4              OTHER COMPANION ANIMAL PHARMACEUTICALS
・       TABLE 14.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR OTHER COMPANION ANIMAL PHARMACEUTICALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3             DERMATOLOGIC DISEASES
7.3.1              GROWING CASES OF DERMATOLOGIC DISEASES HAVE INCREASED THE DEMAND FOR VETERINARY PHARMACEUTICALS.. 93
・       TABLE 15.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR DERMATOLOGIC DISEASES,  BY COUNTRY, 2019–2026 (USD MILLION)
7.4             PAIN
7.4.1              RISING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE SUPPORT MARKET GROWTH
・       TABLE 16.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR PAIN, BY COUNTRY,  2019–2026 (USD MILLION)
7.5             ORTHOPEDIC DISEASES
7.5.1              GROWING PREVALENCE OF OSTEOARTHRITIS AND THE INCREASING POPULATION OF OBESE PETS HAS INCREASED THE DEMAND FOR ORTHOPEDIC DRUGS
・       TABLE 17.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR ORTHOPEDIC DISEASES,  BY COUNTRY, 2019–2026 (USD MILLION)
7.6             BEHAVIORAL DISORDERS
7.6.1              GROWING AWARENESS AMONG PET OWNERS REGARDING BEHAVIORAL DISORDERS IS EXPECTED TO FUEL THE DEMAND FOR THESE DRUGS
・       TABLE 18.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR BEHAVIORAL DISORDERS,  BY COUNTRY, 2019–2026 (USD MILLION)
7.7             OTHER INDICATIONS
・       TABLE 19.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR OTHER INDICATIONS,  BY COUNTRY, 2019–2026 (USD MILLION)

8.... COMPANION ANIMAL PHARMACEUTICALS MARKET,  BY ANIMAL TYPE

8.1             INTRODUCTION
・       TABLE 20...... COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
8.2             DOGS
8.2.1              DOGS SEGMENT IS EXPECTED TO DOMINATE THE GLOBAL MARKET DURING THE FORECAST PERIOD
・       FIGURE 35............... POPULATION OF PET DOGS IN INDIA (MILLION)
・       FIGURE 36............ POPULATION OF PET DOGS GLOBALLY (MILLION)
・       TABLE 21.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR DOGS, BY COUNTRY,  2019–2026 (USD MILLION)
8.3             CATS
8.3.1              GROWING RESEARCH ON FELINE HEALTH AND WELLBEING TO SUPPORT THE MARKET GROWTH
・       TABLE 22.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR CATS, BY COUNTRY,  2019–2026 (USD MILLION)
8.4             HORSES
8.4.1              RISING PREVALENCE OF INFECTIOUS DISEASES IN THE EQUINE POPULATION TO DRIVE MARKET GROWTH
・       TABLE 23... HORSE POPULATION, BY REGION, 2016–2019 (MILLION)
・       TABLE 24.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR HORSES, BY COUNTRY,  2019–2026 (USD MILLION)
8.5             OTHER COMPANION ANIMALS
・       TABLE 25.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)

9.... COMPANION ANIMAL PHARMACEUTICALS MARKET,  BY DISTRIBUTION CHANNEL

9.1             INTRODUCTION
・       TABLE 26...... COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL,  2019–2026 (USD MILLION)
9.2             VETERINARY HOSPITALS
9.2.1              VETERINARY HOSPITALS ARE THE LARGEST AND FASTEST-GROWING SEGMENT OF THE COMPANION ANIMAL PHARMACEUTICALS MARKET
・       TABLE 27.. VETERINARY VISIT EXPENSES FOR CATS AND DOGS IN THE US
・       TABLE 28.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR VETERINARY HOSPITALS,  BY COUNTRY, 2019–2026 (USD MILLION)
9.3             VETERINARY CLINICS
9.3.1              INCREASING NUMBER OF PRIVATE CLINICAL PRACTICES TO SUPPORT MARKET GROWTH
・       TABLE 29.. NUMBER OF PRIVATE CLINICAL PRACTICES, BY COUNTRY, 2015 VS. 2019
・       TABLE 30.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR VETERINARY CLINICS,  BY COUNTRY, 2019–2026 (USD MILLION)
9.4             RETAIL PHARMACIES
9.4.1              EASY ACCESSIBILITY OF PHARMACEUTICALS THROUGH PRESCRIPTION AND OTC TO SUPPORT THE MARKET GROWTH
・       TABLE 31.... COMPANION ANIMAL PHARMACEUTICALS MARKET FOR RETAIL PHARMACIES,  BY COUNTRY, 2019–2026 (USD MILLION)

10.. COMPANION ANIMAL PHARMACEUTICALS MARKET, BY REGION

10.1          INTRODUCTION
・       TABLE 32..... COMPANION ANIMAL POPULATION, BY COUNTRY, 2020 (THOUSAND)
・       FIGURE 37....... COMPANION ANIMAL PHARMACEUTICALS MARKET: GEOGRAPHIC SNAPSHOT
・       TABLE 33...... COMPANION ANIMAL PHARMACEUTICALS MARKET, BY REGION,  2019–2026 (USD MILLION)
10.2          NORTH AMERICA
・       FIGURE 38. EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA
・       FIGURE 39....................... NORTH AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET SNAPSHOT
・       TABLE 34......................... NORTH AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 35......................... NORTH AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 36......................... NORTH AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 37......................... NORTH AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
・       TABLE 38......................... NORTH AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.2.1            US
10.2.1.1          THE US DOMINATES THE NORTH AMERICAN COMPANION ANIMAL PHARMACEUTICALS MARKET
・       FIGURE 40... US: INCREASE IN PET EXPENDITURE, 2010–2019 (USD BILLION)
・       TABLE 39. US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2016 VS. 2018
・       TABLE 40 US: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 41 US: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 42 US: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 43 US: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.2.2            CANADA
10.2.2.1          INCREASING PET ADOPTION RATE AND RISING ANIMAL HEALTH AWARENESS TO SUPPORT MARKET GROWTH IN CANADA
・       TABLE 44......... CANADA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 45......... CANADA: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 46......... CANADA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 47......... CANADA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION). 128
10.3          EUROPE
・       TABLE 48......... EUROPE: NUMBER OF VETERINARIANS, 2012–2018
・       TABLE 49......... EUROPE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
・       TABLE 50......... EUROPE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 51......... EUROPE: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 52......... EUROPE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 53......... EUROPE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION). 131
10.3.1            GERMANY
10.3.1.1          GERMANY HELD THE LARGEST SHARE OF THE EUROPEAN MARKET IN 2020
・       TABLE 54 GERMANY: COMPANION ANIMAL POPULATION, 2012–2018 (MILLION)
・       TABLE 55....... GERMANY: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 56....... GERMANY: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 57....... GERMANY: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 58....... GERMANY: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.2            UK
10.3.2.1          GROWING PET OWNERSHIP RATES TO DRIVE MARKET GROWTH
・       TABLE 59........ UK: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION)
・       TABLE 60 UK: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 61 UK: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 62 UK: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 63 UK: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.3            FRANCE
10.3.3.1          PRESENCE OF MAJOR PLAYERS IN THE COUNTRY IS EXPECTED TO PROPEL THE COMPANION ANIMAL PHARMACEUTICALS MARKET
・       TABLE 64. FRANCE: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION)
・       TABLE 65. FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2016 VS. 2018
・       TABLE 66.......... FRANCE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 67.......... FRANCE: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 68.......... FRANCE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 69.......... FRANCE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION). 138
10.3.4            SPAIN
10.3.4.1          INCREASING ANIMAL HEALTH EXPENDITURE IS PROPELLING MARKET GROWTH IN SPAIN
・       TABLE 70.... SPAIN: COMPANION ANIMAL POPULATION, 2014–2018 (MILLION)
・       TABLE 71 SPAIN: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 72. SPAIN: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 73 SPAIN: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 74 SPAIN: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.5            ITALY
10.3.5.1          GROWING ANIMAL HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH
・       TABLE 75..... ITALY: COMPANION ANIMAL POPULATION, 2016–2018 (MILLION)
・       TABLE 76......... ITALY: NUMBER OF VETERINARIANS, 2016 VS. 2019
・       TABLE 77. ITALY: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 78.. ITALY: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 79. ITALY: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 80. ITALY: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.3.6            REST OF EUROPE
・       TABLE 81... ROE: COMPANION ANIMAL OWNERSHIP, 2018 (MILLION)
・       TABLE 82........... COMPANION ANIMAL POPULATION IN THE REST OF EUROPE, 2019 (MILLION)
・       TABLE 83......................... ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2016 VS. 2019
・       TABLE 84.. ROE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 85... ROE: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 86.. ROE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 87.. ROE: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION). 145
10.4          ASIA PACIFIC
・       FIGURE 41. ASIA PACIFIC: COMPANION ANIMAL PHARMACEUTICALS MARKET SNAPSHOT
・       TABLE 88... ASIA PACIFIC: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
・       TABLE 89... ASIA PACIFIC: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 90... ASIA PACIFIC: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 91... ASIA PACIFIC: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
・       TABLE 92... ASIA PACIFIC: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION). 149
10.4.1            CHINA
10.4.1.1          CHINA DOMINATES THE COMPANION ANIMAL PHARMACEUTICALS MARKET
・       FIGURE 42... CHINA: PROJECTED COMPANION ANIMAL POPULATION, 2018–2025 (MILLION)
・       TABLE 93 CHINA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 94 CHINA: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 95 CHINA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 96 CHINA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.2            JAPAN
10.4.2.1          RISING DEMAND FOR IMPORTED BREEDS IS DRIVING PET ADOPTION RATES IN THE COUNTRY
・       TABLE 97........ JAPAN: NUMBER OF VETERINARIANS, 2016 VS. 2019
・       TABLE 98 JAPAN: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 99 JAPAN: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 100.......... JAPAN: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 101.......... JAPAN: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION). 154
10.4.3            INDIA
10.4.3.1          INDIA IS AN UNTAPPED MARKET WITH LARGE GROWTH POTENTIAL IN COMPANION ANIMAL PHARMACEUTICALS
・       FIGURE 43.... INDIA: PROJECTED COMPANION ANIMAL POPULATION, 2018–2025 (MILLION)
・       TABLE 102 INDIA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 103 INDIA: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 104 INDIA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 105 INDIA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.4.4            SOUTH KOREA
10.4.4.1          RISING PET POPULATION AND GROWING AWARENESS ABOUT ANIMAL HEALTH TO SUPPORT MARKET GROWTH
・       TABLE 106 SOUTH KOREA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 107 SOUTH KOREA: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 108 SOUTH KOREA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
・       TABLE 109 SOUTH KOREA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION). 159
10.4.5            REST OF ASIA PACIFIC
・       FIGURE 44............... AUSTRALIA: PROJECTED COMPANION ANIMAL POPULATION,  2018–2025 (MILLION)
・       TABLE 110....... ROAPAC: NUMBER OF VETERINARIANS, 2012−2019
・       TABLE 111....... ROAPAC: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION,  2019–2026 (USD MILLION)
・       TABLE 112....... ROAPAC: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 113....... ROAPAC: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE,  2019–2026 (USD MILLION)
・       TABLE 114....... ROAPAC: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION). 162
10.5          LATIN AMERICA
10.5.1            RISING POOL OF SKILLED VETERINARIANS AND GROWING PET HEALTH EXPENDITURE TO DRIVE THE MARKET GROWTH
・       TABLE 115..... NUMBER OF VETERINARIANS AND VETERINARY PARA-PROFESSIONALS IN LATIN AMERICAN COUNTRIES, 2016 VS. 2019
・       TABLE 116......................... LATIN AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 117......................... LATIN AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 118......................... LATIN AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
・       TABLE 119......................... LATIN AMERICA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)
10.6          MIDDLE EAST & AFRICA
10.6.1            GROWING POPULATION OF COMPANION ANIMALS TO PROPEL MARKET GROWTH
・       TABLE 120 AFRICA: NUMBER OF VETERINARIANS, 2012 VS. 2017 VS. 2019
・       TABLE 121.............. MIDDLE EAST & AFRICA: COMPANION ANIMAL PHARMACEUTICALS MARKET,  BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 122.............. MIDDLE EAST & AFRICA: COMPANION ANIMAL PHARMACEUTICALS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 123.............. MIDDLE EAST & AFRICA: COMPANION ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
・       TABLE 124.............. MIDDLE EAST & AFRICA: COMPANION ANIMAL PHARMACEUTICALS MARKET,  BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION)

11.. COMPETITIVE LANDSCAPE

11.1          OVERVIEW
11.2          KEY PLAYER STRATEGIES ADOPTED BY MARKET PLAYERS FROM JANUARY 2017 TO FEBRUARY 2021
11.3          GEOGRAPHICAL FOOTPRINT OF THE MAJOR PLAYERS IN THE COMPANION ANIMAL PHARMACEUTICALS MARKET
・       FIGURE 45......... GEOGRAPHIC REVENUE MIX: COMPANION ANIMAL PHARMACEUTICALS MARKET (2020)
11.4          COMPANY PRODUCT FOOTPRINT
・       FIGURE 46... PRODUCT PORTFOLIO ANALYSIS: COMPANION ANIMAL PHARMACEUTICALS MARKET
11.5          REVENUE SHARE ANALYSIS OF THE TOP PLAYERS
・       FIGURE 47.. REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE COMPANION ANIMAL PHARMACEUTICALS MARKET (2015–2019)
11.6          MARKET SHARE ANALYSIS
・       FIGURE 48........ COMPANION ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2020
11.7          MARKET EVALUATION FRAMEWORK
・       FIGURE 49. MARKET EVALUATION FRAMEWORK: ACQUISITIONS—THE MOST WIDELY ADOPTED STRATEGY
11.8          COMPETITIVE LEADERSHIP MAPPING
11.8.1            STARS
11.8.2            EMERGING LEADERS.. 175
11.8.3            PERVASIVE PLAYERS.. 176
11.8.4            PARTICIPANTS
・       FIGURE 50....... COMPANION ANIMAL PHARMACEUTICALS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
11.9          COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
11.9.1            PROGRESSIVE COMPANIES
11.9.2            DYNAMIC COMPANIES.. 178
11.9.3            STARTING BLOCKS.. 178
11.9.4            RESPONSIVE COMPANIES
・       FIGURE 51....... COMPANION ANIMAL PHARMACEUTICALS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
11.10        COMPETITIVE SITUATION AND TRENDS
11.10.1         PRODUCT LAUNCHES & APPROVALS
・       TABLE 125........................... PRODUCT LAUNCHES & APPROVALS
11.10.2         EXPANSIONS
・       TABLE 126......................................................... EXPANSIONS
11.10.3         ACQUISITIONS
・       TABLE 127....................................................... ACQUISITIONS
11.10.4         AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
・       TABLE 128... AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS

12.. COMPANY PROFILES

12.1          KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
12.1.1            ZOETIS INC.
・       TABLE 129.............................. ZOETIS INC.: BUSINESS OVERVIEW
・       FIGURE 52......................... ZOETIS: COMPANY SNAPSHOT (2020)
12.1.2            MERCK & CO., INC.
・       TABLE 130.................... MERCK & CO., INC.: BUSINESS OVERVIEW
・       FIGURE 53.......... MERCK & CO., INC.: COMPANY SNAPSHOT (2020)
12.1.3            BOEHRINGER INGELHEIM GMBH
・       TABLE 131... BOEHRINGER INGELHEIM GMBH: BUSINESS OVERVIEW
・       FIGURE 54.. BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT (2019)
12.1.4            ELANCO ANIMAL HEALTH INCORPORATED
・       TABLE 132..... ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW
・       FIGURE 55..... ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2019)
12.1.5            CEVA SANTÉ ANIMALE
・       TABLE 133................ CEVA SANTÉ ANIMALE: BUSINESS OVERVIEW
12.1.6            VIRBAC
・       TABLE 134................................... VIRBAC: BUSINESS OVERVIEW
・       FIGURE 56......................... VIRBAC: COMPANY SNAPSHOT (2019)
12.1.7            VETOQUINOL S.A. 208
・       TABLE 135...................... VETOQUINOL S.A.: BUSINESS OVERVIEW
・       FIGURE 57............ VETOQUINOL S.A.: COMPANY SNAPSHOT (2019)
12.1.8            DECHRA PHARMACEUTICALS PLC
・       TABLE 136. DECHRA PHARMACEUTICALS PLC: BUSINESS OVERVIEW
・       FIGURE 58. DECHRA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2019)
12.1.9            CHANELLE PHARMA.. 215
・       TABLE 137................... CHANELLE PHARMA: BUSINESS OVERVIEW
12.1.10         KYORITSU SEIYAKU
・       TABLE 138.................... KYORITSU SEIYAKU: BUSINESS OVERVIEW
12.1.11         ZYDUS ANIMAL HEALTH AND INVESTMENTS LIMITED
・       TABLE 139....... ZYDUS ANIMAL HEALTH AND INVESTMENTS LIMITED: BUSINESS OVERVIEW
・       FIGURE 59....... ZYDUS ANIMAL HEALTH AND INVESTMENTS LIMITED: COMPANY SNAPSHOT (2019)
12.1.12         TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD.
・       TABLE 140.. TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
12.1.13         HIPRA
・       TABLE 141..................................... HIPRA: BUSINESS OVERVIEW
12.1.14         NORBROOK HOLDINGS LIMITED
・       TABLE 142.... NORBROOK HOLDINGS LIMITED: BUSINESS OVERVIEW
12.1.15         INOVET
・       TABLE 143................................... INOVET: BUSINESS OVERVIEW
12.2          OTHER PLAYERS
12.2.1            ENDOVAC ANIMAL HEALTH
12.2.2            ECO ANIMAL HEALTH GROUP PLC
12.2.3            INDIAN IMMUNOLOGICALS LTD.
12.2.4            ASHISH LIFE SCIENCE PVT. LTD.
12.2.5            LUTIM PHARMA PVT. LTD.
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13.. APPENDIX

当レポートのプレスリリースは発行されておりません。